Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons.

Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells.

Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells.

Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells.

Tumor necrosis factor-beta induces sleep, fever, and anorexia.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

p,p'-DDE induces apoptosis through the modulation of tumor necrosis factor α in PC12 cells.

Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells.

Tumor necrosis factor-alpha induces clustering in ovarian theca-interstitial cells in vitro.

Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.

Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro.

Tumor necrosis factor and hypermetabolism.

Intra-abdominal sepsis alters tumor necrosis factor-alpha and interleukin-1 beta binding to human neutrophils.

Tumor necrosis factor-alpha alters bovine luteal cell synthetic capacity and viability.

Tumor necrosis factor-alpha.

Tumor necrosis factor-α induces interleukin-34 expression through nuclear factor‑κB activation in MC3T3-E1 osteoblastic cells.

Eicosanoids, mesangial contraction, and intracellular signal transduction.

Tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and induces apoptosis of prostate and bladder cancer cells.

Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule.

Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody.

Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange.

Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis.

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.

Suggest Documents

Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells.

Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells.

Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells.

Tumor necrosis factor-beta induces sleep, fever, and anorexia.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

p,p'-DDE induces apoptosis through the modulation of tumor necrosis factor α in PC12 cells.

Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells.

Tumor necrosis factor-alpha induces clustering in ovarian theca-interstitial cells in vitro.

Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.

Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro.

Tumor necrosis factor and hypermetabolism.

Intra-abdominal sepsis alters tumor necrosis factor-alpha and interleukin-1 beta binding to human neutrophils.

Tumor necrosis factor-alpha alters bovine luteal cell synthetic capacity and viability.

Tumor necrosis factor-alpha.

Tumor necrosis factor-α induces interleukin-34 expression through nuclear factor‑κB activation in MC3T3-E1 osteoblastic cells.

Eicosanoids, mesangial contraction, and intracellular signal transduction.

Tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and induces apoptosis of prostate and bladder cancer cells.

Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule.

Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody.

Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange.

Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis.

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.

Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons.

Recommend Documents

Follow Us